Delivering light therapy using a remotely controlled bioelectronic device implanted above the brain might complement current glioblastoma therapies, reducing cancer recurrence and improving survival.
References
Ostrom, Q. T. et al. Neuro. Oncol. 22, iv1–iv96 (2020).
Arami, H. et al. Nat. Nanotechnol. https://doi.org/10.1038/s41565-022-01189-y (2022).
Huang, X. et al. Lasers Med. Sci. 23, 217–228 (2008).
Campos, B. et al. Oncogene 35, 5819–5825 (2016).
Ng, C. W. et al. Adv. Funct. Mater. 28, 1804688 (2018).
Neuroinfuse Drug Delivery System. https://www.renishaw.com/en/neuroinfuse-drug-delivery-system--42358
Bansal, A. et al. PNAS 115, 1469–1474 (2018).
Greicius, J. And yet, you try. Stanford Medicine https://stanmed.stanford.edu/2016fall/milan-gambhirs-li-fraumeni-syndrome.html (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J.S.H. is a scientific advisor to Incando Therapeutics, a biotherapeutics company developing phototherapy treatments for hard-to-treat cancers and other diseases.
Rights and permissions
About this article
Cite this article
Ho, J.S., Zhang, Y. Wireless nanomedicine for brain tumors. Nat. Nanotechnol. 17, 907–908 (2022). https://doi.org/10.1038/s41565-022-01188-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41565-022-01188-z
- Springer Nature Limited
This article is cited by
-
Why converging technologies need converging international regulation
Ethics and Information Technology (2024)
-
Customizing delivery nano-vehicles for precise brain tumor therapy
Journal of Nanobiotechnology (2023)